# Innate Pharma SA: Form 6-K, filed Jul 7, 2025

- Company: [Innate Pharma SA](/companies/ipha.md) (CIK 1598599)
- Form: 6-K
- Filed: 2025-07-07
- Accepted by EDGAR: Jul 7, 2025, 06:03 ET
- Period: 2025-07-04
- Accession: 0001598599-25-000062
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1598599/000159859925000062/a6k-iphx250704.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1598599/000159859925000062/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1598599/000159859925000062/a6k-iphx250704.htm

Filed Jul 7, 2025.
Source: SEC EDGAR, the filing index for accession 0001598599-25-000062. Last ingested by Listed: Nov 12, 2026, 17:11 ET. No prices; not investment advice.
